ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd - iohexol - תמיסה להזרקה - iohexol 518 mg/ml - iohexol - iohexol - x-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and ct- enhancement. lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract.

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd - iohexol - תמיסה להזרקה - iohexol 647 mg/ml - iohexol - iohexol - x-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and ct- enhancement. lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract.

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd - iohexol - תמיסה להזרקה - iohexol 755 mg/ml - iohexol - iohexol - x-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and ct- enhancement. lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - rotavirus g1 reassortant; rotavirus g2 reassortant; rotavirus g3 reassortant; rotavirus g4 reassortant; rotavirus p1a[8] reassortant - suspension - rotavirus p1a[8] reassortant 2.3 x10 ^6 iu/dose; rotavirus g2 reassortant 2.8 x10 ^6 iu/dose; rotavirus g4 reassortant 2.0 x10^ 6 iu/dose; rotavirus g3 reassortant 2.2 x10 ^6 iu/dose; rotavirus g1 reassortant 2.2 x10 ^6 iu/dose - rota virus diarrhea vaccines - rotateq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes g1, g2, g3, and g4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. the first dose of rorateq should be administered betwen 6 and 12 weeks of age.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - iohexol - תמיסה להזרקה - iohexol 647 mg / 1 ml - iohexol

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - iohexol - תמיסה להזרקה - iohexol 755 mg / 1 ml - iohexol

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - live attenuated human rotavirus rix4414 strain - תרחיף - live attenuated human rotavirus rix4414 strain - rota virus, live attenuated - rota virus, live attenuated - rotarix is indicated for the active immunization of infants from the age of 6 weeks for prevention of gastro-enteritis due to rotavirus infection. in clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of types g1p[8], g2p[4], g3p[8], g4p[8] and g9p[8]. the use of rotarix should be based on official recommendations.

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd, israel - a/cambodia/e0826360/2020 (h3n2)-like strain; a/victoria/2570/2019 (h1n1)pdm09-like strain; b/washington/02/2019 (b/victoria lineage)-like virus - תרחיף להזרקה - b/washington/02/2019 (b/victoria lineage)-like virus 15 mcg/dose / 0.5 ml; a/cambodia/e0826360/2020 (h3n2)-like strain 15 mcg / 0.5 ml; a/victoria/2570/2019 (h1n1)pdm09-like strain 15 mcg / 0.5 ml - influenza, inactivated, split virus or surface antigen - influenza, inactivated, whole virus - influenza virus vaccine.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - hepatitis a virus antigen, inactivated - תרחיף להזרקה - hepatitis a virus antigen, inactivated 1440 e.l.u/ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - active immunisation against infections caused by hepatitis a virus.the vaccine is particularly indicated for those at increased risk of infection or transmission.